STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3645 by analyst upside · 2026-06-27
BLLN
BillionToOne, Inc.
Healthcare · Market Cap $5B · P/E 207.3x
ANALYST PRICE TARGET
-0.4%
implied upside to consensus target
Current Price $118.17
Consensus Target $117.71
Bull Target $145.0
Bear Target $90.0
Analysts Covering 7
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
4
Hold
2
Sell
0
52-Week Low $61.96
52-Week High $138.7
YTD Return +32.3%
FUNDAMENTALS
Market Cap $5B
P/E Ratio (TTM) 207.3x
Forward P/E 114.7x
EPS (TTM) $0.57
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $355M
Profit Margin 7.0%
52-WEEK RANGE
52-Week Low $61.96
52-Week High $138.7
Current Price $118.17
Bear Target $90.0
Bull Target $145.0
● Now $118.17 ● Target $117.71
TRADING DATA
Avg Volume 660K
YTD Return +32.3%
Analyst Count 7
Consensus Buy
Upside to Target -0.4%
Last Updated 2026-06-27

ANALYST SUMMARY

BillionToOne, Inc. (BLLN) is currently trading at $118.17 with a Wall Street consensus price target of $117.71, which is 0.4% below the current price over the next 12 months. 7 analysts currently cover BLLN, with a consensus rating of Buy - 75% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $145.0, while the most cautious has a target of $90.0.

BLLN operates in the Healthcare sector with a market capitalisation of $5B. The stock is up 32.3% year-to-date and is currently trading near the upper end of its 52-week range of $61.96 – $138.7.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for BLLN, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Guggenheim — Reiterated
Buy → Buy 2026-05-13 62% win rate (8 calls)
JP Morgan — Reiterated
Overweight → Overweight 2026-05-07 43% win rate (7 calls)
BTIG — Reiterated
Buy → Buy 2026-05-07 38% win rate (8 calls)
Guggenheim — Reiterated
Buy → Buy 2026-03-30 62% win rate (8 calls)
Wells Fargo — Reiterated
Equal-Weight → Equal-Weight 2026-03-05 Building track record
Guggenheim reit
Buy → Buy 2026-03-05 62% win rate (8 calls)
BTIG — Reiterated
Buy → Buy 2026-03-05 38% win rate (8 calls)
JP Morgan — Reiterated
Overweight → Overweight 2025-12-10 43% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
51
out of 100
Coverage depth
16/30
Consensus clarity
21/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →